0001235802-21-000116.txt : 20210831
0001235802-21-000116.hdr.sgml : 20210831
20210831163105
ACCESSION NUMBER: 0001235802-21-000116
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210830
FILED AS OF DATE: 20210831
DATE AS OF CHANGE: 20210831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STANKOVICH THOMAS
CENTRAL INDEX KEY: 0001181166
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37897
FILM NUMBER: 211227384
MAIL ADDRESS:
STREET 1: 1001 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ReShape Lifesciences Inc.
CENTRAL INDEX KEY: 0001427570
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
BUSINESS PHONE: 949-429-6680
MAIL ADDRESS:
STREET 1: 1001 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
FORMER COMPANY:
FORMER CONFORMED NAME: OBALON THERAPEUTICS INC
DATE OF NAME CHANGE: 20080220
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-08-30
0
0001427570
ReShape Lifesciences Inc.
RSLS
0001181166
STANKOVICH THOMAS
1001 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
Chief Financial Officer
Common Stock, $0.001 par value per share
2021-08-30
4
P
0
15000
3.429
A
32613
D
(1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.38 to $3.46, inclusive. The reporting person undertakes to provide to ReShape Lifesciences Inc., any security holder of ReShape Lifesciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
/s/ Thomas Stankovich
2021-08-31